
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling
Sara Sáez-Atiénzar, Luis Bonet‐Ponce, Rafael Blesa, et al.
Cell Death and Disease (2014) Vol. 5, Iss. 8, pp. e1368-e1368
Open Access | Times Cited: 94
Sara Sáez-Atiénzar, Luis Bonet‐Ponce, Rafael Blesa, et al.
Cell Death and Disease (2014) Vol. 5, Iss. 8, pp. e1368-e1368
Open Access | Times Cited: 94
Showing 1-25 of 94 citing articles:
Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
Mei Yue, Kelly M. Hinkle, Paul Davies, et al.
Neurobiology of Disease (2015) Vol. 78, pp. 172-195
Open Access | Times Cited: 235
Mei Yue, Kelly M. Hinkle, Paul Davies, et al.
Neurobiology of Disease (2015) Vol. 78, pp. 172-195
Open Access | Times Cited: 235
LRRK2 links genetic and sporadic Parkinson's disease
Jillian H. Kluss, Adamantios Mamais, Mark Cookson
Biochemical Society Transactions (2019) Vol. 47, Iss. 2, pp. 651-661
Open Access | Times Cited: 191
Jillian H. Kluss, Adamantios Mamais, Mark Cookson
Biochemical Society Transactions (2019) Vol. 47, Iss. 2, pp. 651-661
Open Access | Times Cited: 191
Targeting autophagy-related protein kinases for potential therapeutic purpose
Honggang Xiang, Jifa Zhang, Congcong Lin, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 4, pp. 569-581
Open Access | Times Cited: 189
Honggang Xiang, Jifa Zhang, Congcong Lin, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 4, pp. 569-581
Open Access | Times Cited: 189
Mitochondrial dysfunction in Parkinson’s disease
Qingsong Hu, Guanghui Wang
Translational Neurodegeneration (2016) Vol. 5, Iss. 1
Open Access | Times Cited: 182
Qingsong Hu, Guanghui Wang
Translational Neurodegeneration (2016) Vol. 5, Iss. 1
Open Access | Times Cited: 182
LRRK2 at the interface of autophagosomes, endosomes and lysosomes
Dorien A. Roosen, Mark Cookson
Molecular Neurodegeneration (2016) Vol. 11, Iss. 1
Open Access | Times Cited: 170
Dorien A. Roosen, Mark Cookson
Molecular Neurodegeneration (2016) Vol. 11, Iss. 1
Open Access | Times Cited: 170
LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same
Daniel C. Berwick, George R. Heaton, Sonia Azeggagh, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 146
Daniel C. Berwick, George R. Heaton, Sonia Azeggagh, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 146
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations
Matteo Fields, Annalisa Marcuzzi, Arianna Gonelli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3739-3739
Open Access | Times Cited: 48
Matteo Fields, Annalisa Marcuzzi, Arianna Gonelli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3739-3739
Open Access | Times Cited: 48
Cellular processes associated with LRRK 2 function and dysfunction
Rebecca L. Wallings, Claudia Manzoni, Rina Bandopadhyay
FEBS Journal (2015) Vol. 282, Iss. 15, pp. 2806-2826
Open Access | Times Cited: 153
Rebecca L. Wallings, Claudia Manzoni, Rina Bandopadhyay
FEBS Journal (2015) Vol. 282, Iss. 15, pp. 2806-2826
Open Access | Times Cited: 153
LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infection
Weiwei Liu, Xianan Liu, Yu Li, et al.
The Journal of Experimental Medicine (2017) Vol. 214, Iss. 10, pp. 3051-3066
Open Access | Times Cited: 139
Weiwei Liu, Xianan Liu, Yu Li, et al.
The Journal of Experimental Medicine (2017) Vol. 214, Iss. 10, pp. 3051-3066
Open Access | Times Cited: 139
LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson’s disease
Fiona Bonello, Sidi-Mohamed Hassoun, François Mouton‐Liger, et al.
Human Molecular Genetics (2019) Vol. 28, Iss. 10, pp. 1645-1660
Open Access | Times Cited: 137
Fiona Bonello, Sidi-Mohamed Hassoun, François Mouton‐Liger, et al.
Human Molecular Genetics (2019) Vol. 28, Iss. 10, pp. 1645-1660
Open Access | Times Cited: 137
LRRK2 regulation of immune-pathways and inflammatory disease
Rebecca L. Wallings, Malú G. Tansey
Biochemical Society Transactions (2019) Vol. 47, Iss. 6, pp. 1581-1595
Open Access | Times Cited: 127
Rebecca L. Wallings, Malú G. Tansey
Biochemical Society Transactions (2019) Vol. 47, Iss. 6, pp. 1581-1595
Open Access | Times Cited: 127
Role of the endolysosomal system in Parkinson’s disease
D. J. Vidyadhara, John E. Lee, Sreeganga S. Chandra
Journal of Neurochemistry (2019) Vol. 150, Iss. 5, pp. 487-506
Open Access | Times Cited: 125
D. J. Vidyadhara, John E. Lee, Sreeganga S. Chandra
Journal of Neurochemistry (2019) Vol. 150, Iss. 5, pp. 487-506
Open Access | Times Cited: 125
Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process
Amin Karimi-Moghadam, Saeid Charsouei, Benjamin Bell, et al.
Cellular and Molecular Neurobiology (2018) Vol. 38, Iss. 6, pp. 1153-1178
Open Access | Times Cited: 124
Amin Karimi-Moghadam, Saeid Charsouei, Benjamin Bell, et al.
Cellular and Molecular Neurobiology (2018) Vol. 38, Iss. 6, pp. 1153-1178
Open Access | Times Cited: 124
“LRRK2: Autophagy and Lysosomal Activity”
Marta Madureira, Natalie Connor‐Robson, Richard Wade‐Martins
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 114
Marta Madureira, Natalie Connor‐Robson, Richard Wade‐Martins
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 114
LRRK2 and mitochondria: Recent advances and current views
Alpana Singh, Lianteng Zhi, Hui Zhang
Brain Research (2018) Vol. 1702, pp. 96-104
Open Access | Times Cited: 111
Alpana Singh, Lianteng Zhi, Hui Zhang
Brain Research (2018) Vol. 1702, pp. 96-104
Open Access | Times Cited: 111
Dynamin-related protein 1: A protein critical for mitochondrial fission, mitophagy, and neuronal death in Parkinson’s disease
Sitong Feng, Zhen‐Zhen Wang, Yu‐He Yuan, et al.
Pharmacological Research (2019) Vol. 151, pp. 104553-104553
Closed Access | Times Cited: 100
Sitong Feng, Zhen‐Zhen Wang, Yu‐He Yuan, et al.
Pharmacological Research (2019) Vol. 151, pp. 104553-104553
Closed Access | Times Cited: 100
Mitochondria: A Therapeutic Target for Parkinson’s Disease?
Yu Luo, Alan Hoffer, Barry J. Hoffer, et al.
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 9, pp. 20704-20730
Open Access | Times Cited: 98
Yu Luo, Alan Hoffer, Barry J. Hoffer, et al.
International Journal of Molecular Sciences (2015) Vol. 16, Iss. 9, pp. 20704-20730
Open Access | Times Cited: 98
Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease
Kai Zhang, Shiou Zhu, Jiamei Li, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3015-3034
Open Access | Times Cited: 93
Kai Zhang, Shiou Zhu, Jiamei Li, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 10, pp. 3015-3034
Open Access | Times Cited: 93
Parkinson's: A Disease of Aberrant Vesicle Trafficking
Pawan Singh, Miratul M. K. Muqit
Annual Review of Cell and Developmental Biology (2020) Vol. 36, Iss. 1, pp. 237-264
Open Access | Times Cited: 72
Pawan Singh, Miratul M. K. Muqit
Annual Review of Cell and Developmental Biology (2020) Vol. 36, Iss. 1, pp. 237-264
Open Access | Times Cited: 72
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?
Jean‐Marc Taymans, Elisa Greggio
Current Neuropharmacology (2016) Vol. 14, Iss. 3, pp. 214-225
Open Access | Times Cited: 76
Jean‐Marc Taymans, Elisa Greggio
Current Neuropharmacology (2016) Vol. 14, Iss. 3, pp. 214-225
Open Access | Times Cited: 76
mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1
Claudia Manzoni, Adamantios Mamais, Dorien A. Roosen, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 73
Claudia Manzoni, Adamantios Mamais, Dorien A. Roosen, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 73
On the mechanism underlying ethanol-induced mitochondrial dynamic disruption and autophagy response
Luis Bonet‐Ponce, Sara Sáez-Atiénzar, Carmen da Casa, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2015) Vol. 1852, Iss. 7, pp. 1400-1409
Open Access | Times Cited: 72
Luis Bonet‐Ponce, Sara Sáez-Atiénzar, Carmen da Casa, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2015) Vol. 1852, Iss. 7, pp. 1400-1409
Open Access | Times Cited: 72
Neuroprotective effects of Liriope platyphylla extract against hydrogen peroxide-induced cytotoxicity in human neuroblastoma SH-SY5Y cells
Hee Ra Park, Hee-Eun Lee, Hwayong Park, et al.
BMC Complementary and Alternative Medicine (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 66
Hee Ra Park, Hee-Eun Lee, Hwayong Park, et al.
BMC Complementary and Alternative Medicine (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 66
The LRRK2–macroautophagy axis and its relevance to Parkinson's disease
Claudia Manzoni
Biochemical Society Transactions (2017) Vol. 45, Iss. 1, pp. 155-162
Open Access | Times Cited: 63
Claudia Manzoni
Biochemical Society Transactions (2017) Vol. 45, Iss. 1, pp. 155-162
Open Access | Times Cited: 63
Association between Parkinson’s Disease and Diabetes Mellitus: From Epidemiology, Pathophysiology and Prevention to Treatment
Haiyang Yu, Tong Sun, He Xin, et al.
Aging and Disease (2022) Vol. 13, Iss. 6, pp. 1591-1591
Open Access | Times Cited: 31
Haiyang Yu, Tong Sun, He Xin, et al.
Aging and Disease (2022) Vol. 13, Iss. 6, pp. 1591-1591
Open Access | Times Cited: 31